TABLE 2

HFA and DTH in Patients With CDH Treated With and Without EMCO Until 12 Years of Age

Age (y)ECMONon-ECMO
HFA z scoreDTH z scorePaHFA z scoreDTH z scorePa
0.5−0.31 (−0.61 to −0.10)−0.11 (−0.44 to 0.21).13−0.29 (−0.46 to −0.11)−0.13 (−0.32 to −0.05).009
1−0.43 (−0.73 to −0.13)−0.28 (−0.59 to 0.04).47−0.33 (−0.50 to −0.15)−0.17 (−0.34 to 0.01).004
2−0.71 (−1.02 to −0.40)−0.58 (−0.90 to −0.27).03−0.35 (−0.53 to −0.17)−0.19 (−0.37 to −0.01).042
5−1.08 (−1.38 to −0.78)−0.94 (−1.23 to −0.66).05−0.56 (−0.75 to −0.37)−0.41 (−0.59 to −0.23).027
8−0.94 (−1.25 to −0.63)−0.84 (−1.12 to −0.57).36−0.48 (−0.70 to −0.26)−0.33 (−0.53 to −0.14).045
12−0.67 (−1.01 to −0.67)−0.57 (−0.89 to −0.25).32−0.49 (−0.77 to −0.20)−0.38 (−0.66 to −0.10).19
  • Data are presented as estimated marginal means (95% confidence intervals), and the presentation is based on a general linear model with time point, ECMO, and their interaction effect as independent variables.

  • a P values are based on a comparison of mean z scores of HFA and DTH by using paired samples t tests.